Lite Strategy LITS
NASDAQ LITS
$0.99 +0.05 (+4.91%)
At close: Aug 21, 2026 · 4:00 PM EDT

Lite Strategy (LITS) Cash & Equivalents (2010 - 2026)

Lite Strategy (LITS) posted quarterly Cash & Equivalents of $7.5 million for Q1 2026, down 63.2% year-over-year from $20.5 million in Q1 2025, and down 13.86% quarter-over-quarter from $8.8 million in Q4 2025.

Lite Strategy (LITS) Cash & Equivalents (2010 - 2026) Analysis & Trends

Lite Strategy's Cash & Equivalents history runs 17 years deep, the most recent figure standing at $7.5 million for Q1 2026.

  • In Q1 2026, Cash & Equivalents fell 63.2% year-over-year to $7.5 million; the TTM figure through Mar 2026 stood at $7.5 million (down 63.2% YoY), while the FY2025 annual figure was $18.0 million, up 386.13% from the prior year.
  • Cash & Equivalents for Q1 2026 stood at $7.5 million, down from $8.8 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $169.0 million in Q1 2022, with the low at $2.4 million in Q1 2024.
  • The 5-year median for Cash & Equivalents is $10.1 million (2025), against an average of $27.0 million.
  • The sharpest annual moves came in 2022 and 2023: Cash & Equivalents soared 1634.65% in 2022, then sank 95.83% in 2023.
  • Lite Strategy's Cash & Equivalents stood at $124.2 million in 2022, then tumbled by 95.83% to $5.2 million in 2023, then soared by 358.06% to $23.7 million in 2024, then sank by 63.05% to $8.8 million in 2025, then retreated by 13.86% to $7.5 million in 2026.
  • Business Quant data shows LITS's Cash & Equivalents at $7.5 million in Q1 2026, $8.8 million in Q4 2025, and $10.1 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 6.14 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 2.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 3.58 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 1.72 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 5.10 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 1.71 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 8.93 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 544.80 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 811.99 Mn
10 Lite Strategy 35.71 Mn 28.17 Mn - 7.54 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.54 Mn
Dec 31, 2025 8.76 Mn
Sep 30, 2025 10.11 Mn
Jun 30, 2025 18.01 Mn
Mar 31, 2025 20.50 Mn
Dec 31, 2024 23.70 Mn
Sep 30, 2024 6.95 Mn
Jun 30, 2024 3.71 Mn
Mar 31, 2024 2.37 Mn
Dec 31, 2023 5.17 Mn
Sep 30, 2023 3.37 Mn
Jun 30, 2023 16.91 Mn
Mar 31, 2023 8.81 Mn
Dec 31, 2022 124.17 Mn
Sep 30, 2022 14.65 Mn
Jun 30, 2022 15.74 Mn
Mar 31, 2022 169.04 Mn
Dec 31, 2021 12.55 Mn
Sep 30, 2021 145.50 Mn
Jun 30, 2021 8.54 Mn